The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Neomycin Market Research Report 2025

Global Neomycin Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1900783

No of Pages : 85

Synopsis
Neomycin (CAS 119-04-0), C23H46N6O13, the formula weight is 614.64, and the form is liquid.
The global Neomycin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Neomycin is an antibiotic, together with streptomycin, kanamycin, and gentamicin, is an aminoglycoside antibiotic which is produced by Streptomyces faecalis; it is effective against both Gram-positive and Gram-negative bacteria, and the product is mainly neomycin B. And a mixture of C.
This report aims to provide a comprehensive presentation of the global market for Neomycin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neomycin.
Report Scope
The Neomycin market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neomycin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neomycin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Angene
Aba Chem Scene
MuseChem
Biosynth
DC Chemicals
Chem Strong
Yuanye Biology
Weibo
Segment by Type
98% Purity Type
95% Purity Type
Others
Segment by Application
Neomycin Sulfate Eye Drops
Neomycin Sulfate Tablets
Compound Neomycin Ointment
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neomycin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neomycin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Neomycin Market Overview
1.1 Product Overview and Scope of Neomycin
1.2 Neomycin Segment by Type
1.2.1 Global Neomycin Market Value Comparison by Type (2024-2030)
1.2.2 98% Purity Type
1.2.3 95% Purity Type
1.2.4 Others
1.3 Neomycin Segment by Application
1.3.1 Global Neomycin Market Value by Application: (2024-2030)
1.3.2 Neomycin Sulfate Eye Drops
1.3.3 Neomycin Sulfate Tablets
1.3.4 Compound Neomycin Ointment
1.4 Global Neomycin Market Size Estimates and Forecasts
1.4.1 Global Neomycin Revenue 2019-2030
1.4.2 Global Neomycin Sales 2019-2030
1.4.3 Global Neomycin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Neomycin Market Competition by Manufacturers
2.1 Global Neomycin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Neomycin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Neomycin Average Price by Manufacturers (2019-2024)
2.4 Global Neomycin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Neomycin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neomycin, Product Type & Application
2.7 Neomycin Market Competitive Situation and Trends
2.7.1 Neomycin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Neomycin Players Market Share by Revenue
2.7.3 Global Neomycin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neomycin Retrospective Market Scenario by Region
3.1 Global Neomycin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Neomycin Global Neomycin Sales by Region: 2019-2030
3.2.1 Global Neomycin Sales by Region: 2019-2024
3.2.2 Global Neomycin Sales by Region: 2025-2030
3.3 Global Neomycin Global Neomycin Revenue by Region: 2019-2030
3.3.1 Global Neomycin Revenue by Region: 2019-2024
3.3.2 Global Neomycin Revenue by Region: 2025-2030
3.4 North America Neomycin Market Facts & Figures by Country
3.4.1 North America Neomycin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Neomycin Sales by Country (2019-2030)
3.4.3 North America Neomycin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Neomycin Market Facts & Figures by Country
3.5.1 Europe Neomycin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Neomycin Sales by Country (2019-2030)
3.5.3 Europe Neomycin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neomycin Market Facts & Figures by Country
3.6.1 Asia Pacific Neomycin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Neomycin Sales by Country (2019-2030)
3.6.3 Asia Pacific Neomycin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Neomycin Market Facts & Figures by Country
3.7.1 Latin America Neomycin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Neomycin Sales by Country (2019-2030)
3.7.3 Latin America Neomycin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neomycin Market Facts & Figures by Country
3.8.1 Middle East and Africa Neomycin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Neomycin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Neomycin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Neomycin Sales by Type (2019-2030)
4.1.1 Global Neomycin Sales by Type (2019-2024)
4.1.2 Global Neomycin Sales by Type (2025-2030)
4.1.3 Global Neomycin Sales Market Share by Type (2019-2030)
4.2 Global Neomycin Revenue by Type (2019-2030)
4.2.1 Global Neomycin Revenue by Type (2019-2024)
4.2.2 Global Neomycin Revenue by Type (2025-2030)
4.2.3 Global Neomycin Revenue Market Share by Type (2019-2030)
4.3 Global Neomycin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Neomycin Sales by Application (2019-2030)
5.1.1 Global Neomycin Sales by Application (2019-2024)
5.1.2 Global Neomycin Sales by Application (2025-2030)
5.1.3 Global Neomycin Sales Market Share by Application (2019-2030)
5.2 Global Neomycin Revenue by Application (2019-2030)
5.2.1 Global Neomycin Revenue by Application (2019-2024)
5.2.2 Global Neomycin Revenue by Application (2025-2030)
5.2.3 Global Neomycin Revenue Market Share by Application (2019-2030)
5.3 Global Neomycin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Angene
6.1.1 Angene Corporation Information
6.1.2 Angene Description and Business Overview
6.1.3 Angene Neomycin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Angene Neomycin Product Portfolio
6.1.5 Angene Recent Developments/Updates
6.2 Aba Chem Scene
6.2.1 Aba Chem Scene Corporation Information
6.2.2 Aba Chem Scene Description and Business Overview
6.2.3 Aba Chem Scene Neomycin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Aba Chem Scene Neomycin Product Portfolio
6.2.5 Aba Chem Scene Recent Developments/Updates
6.3 MuseChem
6.3.1 MuseChem Corporation Information
6.3.2 MuseChem Description and Business Overview
6.3.3 MuseChem Neomycin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 MuseChem Neomycin Product Portfolio
6.3.5 MuseChem Recent Developments/Updates
6.4 Biosynth
6.4.1 Biosynth Corporation Information
6.4.2 Biosynth Description and Business Overview
6.4.3 Biosynth Neomycin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biosynth Neomycin Product Portfolio
6.4.5 Biosynth Recent Developments/Updates
6.5 DC Chemicals
6.5.1 DC Chemicals Corporation Information
6.5.2 DC Chemicals Description and Business Overview
6.5.3 DC Chemicals Neomycin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 DC Chemicals Neomycin Product Portfolio
6.5.5 DC Chemicals Recent Developments/Updates
6.6 Chem Strong
6.6.1 Chem Strong Corporation Information
6.6.2 Chem Strong Description and Business Overview
6.6.3 Chem Strong Neomycin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Chem Strong Neomycin Product Portfolio
6.6.5 Chem Strong Recent Developments/Updates
6.7 Yuanye Biology
6.6.1 Yuanye Biology Corporation Information
6.6.2 Yuanye Biology Description and Business Overview
6.6.3 Yuanye Biology Neomycin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Yuanye Biology Neomycin Product Portfolio
6.7.5 Yuanye Biology Recent Developments/Updates
6.8 Weibo
6.8.1 Weibo Corporation Information
6.8.2 Weibo Description and Business Overview
6.8.3 Weibo Neomycin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Weibo Neomycin Product Portfolio
6.8.5 Weibo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neomycin Industry Chain Analysis
7.2 Neomycin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neomycin Production Mode & Process
7.4 Neomycin Sales and Marketing
7.4.1 Neomycin Sales Channels
7.4.2 Neomycin Distributors
7.5 Neomycin Customers
8 Neomycin Market Dynamics
8.1 Neomycin Industry Trends
8.2 Neomycin Market Drivers
8.3 Neomycin Market Challenges
8.4 Neomycin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’